A new study identified and then reverse engineered the molecular properties shared by antibodies that are particularly efficient at inactivating or ‘neutralizing’ Lassa virus. The team’s findings also revealed that most neutralizing antibodies bind to the same spot on the surface of Lassa virus, providing a map for rational vaccine design.